NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

11103	Companies
244247	Keywords
172348	Articles
131623	Press releases

Home
Companies
NANOBIOTIX

PRESS RELEASE

published on 09/17/2025 at 22:15, 1 year ago

NANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resistant to Anti-PD-1
Nanobiotix announces new results from a Phase 1 study evaluating JNJ-1900 (NBTXR3) in combination with immune checkpoint inhibitors as a 2L+ therapy for patients with primary cutaneous melanoma resistant to anti-PD-1. Favorable safety profile and early efficacy signals observed

Melanoma NANOBIOTIX Immune Checkpoint Inhibitors Phase 1 Study JNJ-1900
BRIEF

published on 09/12/2025 at 19:05, 1 year ago

Nanobiotix Announces Voting Rights and Share Capital Details

Voting Rights Shares Euronext Nasdaq NANOBIOTIX
BRIEF

published on 09/12/2025 at 19:05, 1 year ago

Nanobiotix annonce les droits de vote et le détail du capital social

Euronext Actions Nasdaq Droit De Vote NANOBIOTIX
PRESS RELEASE

published on 09/12/2025 at 19:00, 1 year ago

Voting Rights and Shares Capital of the Company
Nanobiotix releases voting rights and shares capital details. The company is listed on Euronext Paris and Nasdaq, pioneering biotechnology for treatment advancements

Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
PRESS RELEASE

published on 09/12/2025 at 19:00, 1 year ago

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Communiqué de presse sur le nombre total de droits de vote et d'actions de Nanobiotix. Informations financières clés et activités de l'entreprise

Droits De Vote Capital Social Biotechnologie Actions NANOBIOTIX
BRIEF

published on 09/02/2025 at 22:20, 1 year ago

Nanobiotix à la conférence H.C. Wainwright Global Investment

Biotechnologie Investisseurs Conference NANOBIOTIX Thérapeutiques
BRIEF

published on 09/02/2025 at 22:20, 1 year ago

Nanobiotix at the HC Wainwright Global Investment Conference

Investors Biotechnology Conference Therapeutics NANOBIOTIX
PRESS RELEASE

published on 09/02/2025 at 22:15, 1 year ago

Nanobiotix participera à la conférence investisseurs annuelle H.C. Wainwright global investment
Nanobiotix participe à la conférence investisseurs annuelle H.C. Wainwright Global Investment pour présenter ses avancées en biotechnologie pour le traitement du cancer et d'autres maladies

Biotechnologie Conférence Investisseurs Cancer NANOBIOTIX Maladies
PRESS RELEASE

published on 09/02/2025 at 22:15, 1 year ago

Nanobiotix to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Nanobiotix to participate in H.C. Wainwright 27th Annual Global Investment Conference with a fireside chat featuring company management. Nanoparticle-based treatments for cancer and major diseases

Fireside Chat NANOBIOTIX H.C. Wainwright Conference Late-stage Biotechnology Nanoparticle-based Treatments
BRIEF

published on 08/27/2025 at 08:05, 1 year 1 month ago

Nanobiotix Announces Voting Rights and Shares Capital Update

Euronext Paris Voting Rights Biotechnology Shares Capital NANOBIOTIX

Accesswire

Published on 09/30/2026 at 20:35, 1 hour 24 minutes ago

Fairplay Ventures Inc. Enters Into Definitive Agreement to Complete Qualifying Transaction With Ampere Metals Pty. Limited
Published on 09/30/2026 at 15:50, 6 hours 9 minutes ago

Innodata Opens Motion-Capture AI Lab to Help Humanoids Move Like Humans
Published on 09/30/2026 at 14:37, 7 hours 22 minutes ago

NuRAN Leverages Starlink Backhaul to Drive Higher Revenue Per Rural Site
Published on 09/30/2026 at 14:31, 7 hours 28 minutes ago

First Breach Expands Ammunition Manufacturing Operations to Seven Days a Week
Published on 09/30/2026 at 14:07, 7 hours 52 minutes ago

Worksport COR Energy System Now Available Through Amazon

View all ACCESSWIRE

EQS Group

Published on 09/30/2026 at 20:50, 1 hour 9 minutes ago

EQS-Adhoc: Avemio AG: Adverse Audit Opinion on 2025 Consolidated Financial Statements and Group Management Report – 2025 Annual Report Published
Published on 09/30/2026 at 19:45, 2 hours 14 minutes ago

PATRIMOINE ET COMMERCE: MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2026
Published on 09/30/2026 at 19:30, 2 hours 29 minutes ago

EEII AG: Half Year Results as of June 30th, 2026
Published on 09/30/2026 at 18:39, 3 hours 19 minutes ago

Advanced Blockchain AG Publishes 2026 Half-Year Report and Advances ABAG 2.0 Strategy
Published on 09/30/2026 at 18:26, 3 hours 33 minutes ago

Kaufman & Broad SA: RESULTATS DES NEUF PREMIERS MOIS DE 2026

Les Echos

Published on 09/30/2026 at 18:44, 3 hours 14 minutes ago

Broadcast of the 5th edition of “On the way up”
Published on 09/30/2026 at 18:44, 3 hours 14 minutes ago

Diffusion de la 5e édition de “On the way up”
Published on 09/30/2026 at 18:18, 3 hours 41 minutes ago

Nombre total de droits de vote et d'actions composant le capital social
Published on 09/30/2026 at 18:15, 3 hours 44 minutes ago

The Belgian State and ENGIE Group have agreed to extend the target date for concluding the Heads of Terms until 4 november 2026
Published on 09/30/2026 at 18:15, 3 hours 44 minutes ago

L’État belge et le groupe ENGIE ont convenu de reporter au 4 novembre 2026 la date cible pour la conclusion des Heads of Terms

View all LES ECHOS COMFI WIRE